Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia
specificA myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines. (WHO, 2001)
Top Centers for Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia
Ranked by research excellence score (trials · grants · publications). Methodology →
No centers currently specializing in this cancer type.
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →